These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 20868717)

  • 1. Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation.
    Nath DS; Angaswamy N; Basha HI; Phelan D; Moazami N; Ewald GA; Mohanakumar T
    Hum Immunol; 2010 Dec; 71(12):1191-6. PubMed ID: 20868717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.
    Nath DS; Ilias Basha H; Tiriveedhi V; Alur C; Phelan D; Ewald GA; Moazami N; Mohanakumar T
    J Heart Lung Transplant; 2010 Nov; 29(11):1277-85. PubMed ID: 20615726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of major histocompatibility complex class I chain-related molecule A (MICA) antibodies in live donor renal transplantation - Indian Experience.
    Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Mehra N
    Scand J Immunol; 2020 Nov; 92(5):e12923. PubMed ID: 32593197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.
    Nath DS; Tiriveedhi V; Basha HI; Phelan D; Moazami N; Ewald GA; Mohanakumar T
    Transplantation; 2011 May; 91(9):1036-43. PubMed ID: 21383658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and MICA: targets of antibody-mediated rejection in heart transplantation.
    Zhang Q; Cecka JM; Gjertson DW; Ge P; Rose ML; Patel JK; Ardehali A; Kobashigawa JA; Fishbein MC; Reed EF
    Transplantation; 2011 May; 91(10):1153-8. PubMed ID: 21544036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
    Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
    Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and impact of HLA and MICA allele mismatching on donor-specific antibodies induction in kidney transplant rejection.
    Romphruk AV; Simtong P; Suntornnipat J; Sudwilai Y; Cheunta S; Chan-On C; Leelayuwat C
    Nephrology (Carlton); 2021 Oct; 26(10):833-841. PubMed ID: 34197005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
    Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MICA and AT1R antibodies with antibody-mediated rejection and cardiac allograft vasculopathy in a pediatric heart transplant recipient.
    Chou-Wu E; Kemna M; Ross S; Youngs D; Law Y; Gimferrer I
    Transpl Immunol; 2023 Jun; 78():101811. PubMed ID: 36889546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.
    Pazdernik M; Bedanova H; Chen Z; Kautzner J; Melenovsky V; Malek I; Slavcev A; Bartonova M; Karmazin V; Eckhardt T; Tomasek A; Ozabalova E; Kovarnik T; Wohlfahrt P; Sonka M
    Transpl Immunol; 2021 Apr; 65():101340. PubMed ID: 33069814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
    Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
    Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
    Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
    J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation.
    Cox ST; Stephens HA; Fernando R; Karasu A; Harber M; Howie AJ; Powis S; Zou Y; Stastny P; Madrigal JA; Little AM
    Hum Immunol; 2011 Oct; 72(10):827-34. PubMed ID: 21664940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
    J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
    Hodges AM; Lyster H; McDermott A; Rice AJ; Smith JD; Rose ML; Banner NR
    Transplantation; 2012 Mar; 93(6):650-6. PubMed ID: 22245878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of anti-human leukocyte antigen, anti-major histocompatibility complex class 1 chain-related antigen a, and anti-glutathione transferase-T1 antibodies on the long-term survival of renal allograft.
    Akgul SU; Oğuz FS; Çalışkan Y; Kekik C; Çağatay P; Türkmen A; Nane I; Aydın F; Temurhan S
    Transplant Proc; 2013 Apr; 45(3):890-4. PubMed ID: 23622580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance.
    Svobodova E; Gazdic T; Kubanek M; Vymetalova J; Voska L; Kment M; Lanska V; Kolesar L; Urban M; Netuka I; Pirk J; Melenovsky V; Kautzner J; Slavcev A; Malek I
    Transpl Int; 2016 Jan; 29(1):63-72. PubMed ID: 26340387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
    Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
    J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MICA antibodies are related to adverse outcome in heart transplant recipients.
    Kauke T; Kaczmarek I; Dick A; Schmoeckel M; Deutsch MA; Beiras-Fernandez A; Reichart B; Spannagl M
    J Heart Lung Transplant; 2009 Apr; 28(4):305-11. PubMed ID: 19332255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.